Authors: Giammarile, F Mognetti, T Resche, I

Citation: F. Giammarile et al., Bone pain palliation with Strontium-89 in cancer patients with bone metastases, Q J NUCL M, 45(1), 2001, pp. 78-83

Authors: Baulieu, JL Resche, I Bardies, M Chauvet, AF Lecloirec, J Malhaire, JP Thomas, E Faurous, P Sassolas, G Pourcelot, L Chatal, JF Guilloteau, D Besnard, JC

Citation: Jl. Baulieu et al., [I-131]-TYR3-octreotide: Clinical dosimetry and use for internal radiotherapy of metastatic paraganglioma and carcinoid tumors, NUCL MED BI, 27(8), 2000, pp. 809-813

Authors: Chatal, JF Le Bodic, MF Kraeber-Bodere, F Rousseau, C Resche, I

Citation: Jf. Chatal et al., Nuclear medicine applications for neuroendocrine tumors, WORLD J SUR, 24(11), 2000, pp. 1285-1289

Authors: Kraeber-Bodere, F Campion, L Rousseau, C Bourdin, S Chatal, JF Resche, I

Citation: F. Kraeber-bodere et al., Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement, EUR J NUCL, 27(10), 2000, pp. 1487-1493

Authors: Kraeber-Bodere, F Bardet, S Hoefnagel, CA Vieira, MR Vuillez, JP Murat, A Ferreira, TC Bardies, M Ferrer, L Resche, I Gautherot, E Rouvier, E Barbet, J Chatal, JF

Citation: F. Kraeber-bodere et al., Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: Preliminary results of a phase I/II clinical trial, CLIN CANC R, 5(10), 1999, pp. 3190S-3198S

Authors: Maublant, J Resche, I Giammarile, F Corone, C Artus, JC

Citation: J. Maublant et al., News on nuclear oncology, B CANCER, 86(1), 1999, pp. 57-64